Why people use PT-141 for post-SSRI sexual dysfunction
SSRI killed your sex drive. PT-141 a real fix? The honest answer: this is an emerging off-label use, early and unproven. PSSD (post-SSRI sexual dysfunction) is poorly understood and lacks approved treatments.
This page covers what's known, what's not, and what the editorial take is for normal humans considering PT-141 for post-SSRI sexual dysfunction.
What the evidence says
Evidence tier: Off-label · emerging. Off-label clinical use with emerging evidence; not FDA-approved for this indication specifically.
- PSSD (post-SSRI sexual dysfunction) is poorly understood and lacks approved treatments.
- PT-141's central nervous system mechanism may bypass the SSRI-affected pathway.
- Anecdotal reports promising; no RCTs specific to PSSD.
Protocol notes
Standard PT-141 dosing. Coordinate with prescribing psychiatrist.
Always with a sports-medicine doctor, telehealth provider, or specialist sign-off. Self-experimenting on injection schedules without clinical input is the most common way people waste money and get hurt.
What to skip
- Vendors without a Certificate of Analysis (COA). Random gym-bro vendors with no third-party testing. The peptide market has a quality-control problem; the answer is COA per peptide, every time.
- Pre-mixed blends from non-pharmacy sources. Compounding pharmacies that produce pre-mixed combinations with COAs are fine. Random vendor "stack vials" are not.
- Massively over-dosed protocols. More is rarely better with peptides. Receptor saturation is real. Stick to evidence-based dosing.
Where to go next
- Full PT-141 directory entry - status, sourcing, studies, what to skip
- What are peptides - if you skipped the foundation
- How peptides actually work - mechanism in plain English
- The Tier List - which ones to take seriously
- Subscribe to the dispatch